GO
Loading...

Drugs

More

  • Colorado's toke tax     Thursday, 9 Jan 2014 | 2:44 PM ET

    CNBC's Jane Wells reports on "high taxes" for recreational pot growers.

  • Pot business forced to pay bills in cash     Thursday, 9 Jan 2014 | 1:54 PM ET

    Starbuds of Denver owner Brian Ruden provides insight into the banking hurdles facing legal pot businesses, and discusses what he would tell his children about the use of marijuana.

  • Banking challenges hit pot businesses     Thursday, 9 Jan 2014 | 1:51 PM ET

    CNBC's Jane Wells spoke with 3D Cannabis Center manager David Martinez about the banking hurdles for legal pot businesses.

  • Pot shortage in Colorado growing?     Thursday, 9 Jan 2014 | 10:24 AM ET

    Colorado consumers have been allowed to legally purchase recreational marijuana for more than a week. CNBC's Jane Wells reports the state is already facing a pot shortage.

  • High Times announces new fund     Tuesday, 7 Jan 2014 | 2:27 PM ET

    CNBC's Josh Lipton reports on the HT Growth Fund, which plans to raise $100 million over the next two years for the legal marijuana market.

  • New York next to join marijuana game?     Monday, 6 Jan 2014 | 4:46 PM ET

    What's turning the tide for the legalization of medical marijuana? CNBC's Jane Wells reports.

  • Marijuana dispensing machine maker Medbox's stock is up 100 percent in the past month. Dr. Bruce Bedrick, Medbox CEO, looks at the growth curve the medical marijuana business could provide.

  • Marijuana on sale in Colorado     Thursday, 2 Jan 2014 | 7:33 PM ET

    Patrick Kennedy, former Rhode Island congressman (D); Andrew Spanswick, Klean Treatment Centers CEO; and Danny Danko, High Times Senior Cultivation editor, discuss the negative impacts the legalization of marijuana may have.

  • Colorado rolls with retail marijuana     Friday, 27 Dec 2013 | 11:36 AM ET

    Tony Verzura, RiverRock owner, discusses Colorado's rigorous pot licensing process and explains how the state is preparing for the rush of recreational buyers expected to hit February 1st.

  • Colorado pot: Lighting the licensing way     Thursday, 26 Dec 2013 | 11:50 AM ET

    Colorado has issued more than 300 licenses to marijuana dispensaries. Dan Danko, High Times Magazine senior editor, discusses how Colorado is properly regulating pot distribution and explains the rigorous application process to obtain a license.

  • Washington pot consumption double estimates     Tuesday, 17 Dec 2013 | 11:58 AM ET

    CNBC's Jane Wells breaks down marijuana usage in Washington and Colorado, and explains how each state is handling weed-smoking visitors.

  • Find the next state trying to legalize marijuana Monday, 16 Dec 2013 | 2:29 PM ET

    New York state lawmakers introduced a bill last week that would legalize the sale, regulation and taxation of marijuana.

  • New York's marijuana legalization push     Monday, 16 Dec 2013 | 11:40 AM ET

    Crystal Peoples-Stokes, Democratic New York Assembly member, discusses the failed war on drugs and her newly introduced marijuana regulation and taxation act that would regulate marijuana like alcohol.

  • Living with a drug addict: The financial realities Wednesday, 11 Dec 2013 | 10:05 AM ET

    Having an addict in the family presents a deeply troubling dilemma. How do you help those you love, while protecting your own financial future?

  • Pharma fights the Superbug     Tuesday, 10 Dec 2013 | 4:53 PM ET

    CNBC's Bertha Coombs reports on the race to treat drug-resistant infections.

  • Seattle throws a pot party     Friday, 6 Dec 2013 | 10:20 AM ET

    Ben Livingston, director of the Center for Legal Cannabis, discusses the legalization anniversary event.

  • Pot entrepreneur: High growth expected for biz Friday, 22 Nov 2013 | 12:53 PM ET

    A Colorado medical marijuana dispensary became the first business in the U.S. licensed to sell recreational marijuana.

  • GlaxoSmithKline heart drug misses goal in major study Tuesday, 12 Nov 2013 | 6:17 AM ET

    An experimental GlaxoSmithKline drug, designed to fight heart disease in a new way, failed to meet its main goal in a major clinical study.

  • Shire to pay $4.2 billion for ViroPharma Monday, 11 Nov 2013 | 4:21 AM ET

    London-listed Shire has agreed to buy U.S. company ViroPharma for about $4.2 billion in cash.

  • FDA weighs generic drugmakers' accountability Friday, 8 Nov 2013 | 5:18 PM ET

    The FDA proposed a new rule that would open up generic drugmakers to liability and apply some of the same regulations used for brand manufacturers.